SCHEMBL6200410

SCHEMBL6200410

[CH2]C=Cc1ccccc1OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 2/20 0.50
ATM Q13315 1/20 0.50
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 4/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
PTGES2 Q9H7Z7 1/20 0.45
AR P10275 1/20 0.45
KDM4E B2RXH2 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 1/20 0.44
MEN1 O00255 1/20 0.44
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6200407 1.00 MAPT (0.50) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL2632229 0.86 MAPT (0.54) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL10436451 0.82 MAPT (0.51) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL28028498 0.82 MAPT (0.51) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL10436448 0.82 MAPT (0.51) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL15789744 0.81 HPGD (0.42) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL60041 0.80 ALDH1A1 (0.50) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL2488791 0.79 ALDH1A1 (0.54) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL2930839 0.79 NFE2L2 (0.65) MAPTSMN1; SMN2LMNAATMALDH1A1
SCHEMBL9063138 0.79 CDK4 (0.65) MAPTSMN1; SMN2LMNAATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed